Short Interest in JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Drops By 9.0%

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the recipient of a significant decline in short interest in January. As of January 15th, there was short interest totalling 459,300 shares, a decline of 9.0% from the December 31st total of 505,000 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

JCR Pharmaceuticals Stock Performance

Shares of OTCMKTS JCRRF opened at $4.57 on Friday. JCR Pharmaceuticals has a 1-year low of $4.30 and a 1-year high of $4.70. The business has a fifty day moving average price of $4.57 and a 200 day moving average price of $4.55.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.